Good morning :)
Place Order
Add to Watchlist

Expleo Solutions Ltd

EXPLEOSOL Share Price

1,052.200.73% (+7.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Information Technology
Software ServicesCybersecurity
Smallcap

With a market cap of ₹1,632 cr, stock is ranked 1,247

High Risk

Stock is 3.34x as volatile as Nifty

EXPLEOSOL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Information Technology
Software ServicesCybersecurity
Smallcap

With a market cap of ₹1,632 cr, stock is ranked 1,247

High Risk

Stock is 3.34x as volatile as Nifty

EXPLEOSOL Performance & Key Metrics

EXPLEOSOL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
15.692.574.75%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
28.907.592.52%

EXPLEOSOL Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
0%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

EXPLEOSOL Company Profile

Expleo Solutions is an India-based holding company. The Company is engaged in providing software testing services.

Investor Presentation

View older View older 

Nov 13, 2025

PDF
View Older Presentations

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 
Persistent Systems Ltd
PERSISTENT
PE Ratio
72.51
72.51
1Y Return
6.86%
6.86%
Buy Reco %
65.63
65.63
Oracle Financial Services Software Ltd
OFSS
PE Ratio
30.05
30.05
1Y Return
33.94%
33.94%
Buy Reco %
100.00
100.00
L&T Technology Services Ltd
LTTS
PE Ratio
38.04
38.04
1Y Return
14.80%
14.80%
Buy Reco %
44.44
44.44
Tata Elxsi Ltd
TATAELXSI
PE Ratio
41.41
41.41
1Y Return
29.18%
29.18%
Buy Reco %
15.38
15.38
Pine Labs Ltd
PINELABS
PE Ratio
-195.44
-195.44
1Y Return
1.30%
1.30%
Buy Reco %
0.00
0.00
Compare with Peers

EXPLEOSOL Sentiment Analysis

EXPLEOSOL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

EXPLEOSOL Stock Summary · November 2025

In Q2 FY '26, the company demonstrated robust growth of 9% year-on-year, primarily fueled by advancements in digital technology and engineering services, while profitability surged with EBITDA rising to 17.1%. Despite challenges such as managing costs during a high furlough period and aligning revenue with headcount growth, optimism prevails, particularly in the banking and financial services sectors, bolstered by a healthy pipeline and favorable foreign exchange rates. Strategic initiatives include potential mergers and acquisitions to enhance service offerings, alongside a commitment to achieving double-digit growth through operational efficiency and a focus on high-margin services. The integration of AI into quality assurance processes is transforming traditional practices, reflecting a broader trend of modernization across sectors, especially in banking and defense, while the aerospace sector shows promise amid ongoing challenges in automotive.

EXPLEOSOL Stock Growth Drivers
EXPLEOSOL Stock Growth Drivers
7
  • Strong Financial Performance

    The company reported a strong quarter with a 9% growth both quarter-on-quarter and year-on-year. Operating

  • Growth in Digital and AI Services

    The company has begun to see revenue generation from its AI services, which has positively

EXPLEOSOL Stock Challenges
EXPLEOSOL Stock Challenges
3
  • Decline in Operating Performance

    Expleo Solutions Limited reported a slight decline in operating revenue of 0.3% at constant currency,

  • Challenges in Aerospace and Automotive Sectors

    The aerospace and automotive sectors are facing significant challenges. While the aerospace segment shows potential

EXPLEOSOL Forecast

EXPLEOSOL Forecasts

Price

Revenue

Earnings

EXPLEOSOL Share Price Forecast

EXPLEOSOL Share Price Forecast

2025
Current
₹1,052.20
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2025
Current
₹1,052.20
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

EXPLEOSOL Company Revenue Forecast

EXPLEOSOL Company Revenue Forecast

2025
Current
₹1.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

Loading...
2025
Current
₹1.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

EXPLEOSOL Stock EPS (Earnings Per Share) Forecast

EXPLEOSOL Stock EPS (Earnings Per Share) Forecast

2025
Current
₹66.52
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2025
Current
₹66.52
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

EXPLEOSOL

EXPLEOSOL

Income

Balance Sheet

Cash Flow

EXPLEOSOL Income Statement

EXPLEOSOL Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 30.22%, vs industry avg of 13.34%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.72% to 1.35%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 20.94%, vs industry avg of 27.34%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue261.01284.50288.77277.99306.31748.58919.41972.381,041.001,082.74
Raw Materialssubtract0.000.000.000.000.000.000.000.000.00900.74
Power & Fuel Costsubtract1.671.521.581.670.992.393.193.884.11
Employee Costsubtract158.01184.12183.36146.41157.09384.04479.89574.84607.86
Selling & Administrative Expensessubtract38.8835.5933.2927.3118.0330.75172.35185.77174.64
Operating & Other expensessubtract20.039.5211.4141.6154.94201.3147.7352.0472.52
Depreciation/Amortizationsubtract5.205.555.505.825.8118.7627.8833.6739.3135.53
Interest & Other Itemssubtract0.200.290.071.111.061.212.262.613.322.91
Taxes & Other Itemssubtract13.2215.9417.3714.1517.9642.4352.2229.1336.0039.51
EPS22.3329.8933.7938.0849.1952.5386.2758.2766.5267.04
DPS24.0024.000.000.000.000.005.000.0050.0050.00
Payout ratio1.070.800.000.000.000.000.060.000.750.75
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

EXPLEOSOL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Nov 13PDF
Aug 14PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 22PDF
Feb 6PDF
Nov 14PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 26PDF
Feb 14PDF
Nov 10PDF
Aug 11PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

EXPLEOSOL Stock Peers

EXPLEOSOL Past Performance & Peer Comparison

EXPLEOSOL Past Performance & Peer Comparison

Comparing 3 stocks from 
Information TechnologySoftware Services

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Expleo Solutions Ltd15.822.574.75%
Persistent Systems Ltd72.5116.070.54%
Oracle Financial Services Software Ltd30.058.553.22%
L&T Technology Services Ltd38.047.901.21%

EXPLEOSOL Stock Price Comparison

Compare EXPLEOSOL with any stock or ETF
Compare EXPLEOSOL with any stock or ETF
EXPLEOSOL
Loading...

EXPLEOSOL Holdings

EXPLEOSOL Shareholdings

EXPLEOSOL Promoter Holdings Trend

EXPLEOSOL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

EXPLEOSOL Institutional Holdings Trend

EXPLEOSOL Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

EXPLEOSOL Shareholding Pattern

EXPLEOSOL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.05%0.00%0.84%0.13%27.99%

Dec 2024

Mar 2025

Jun 2025

Sep 2025

EXPLEOSOL Shareholding History

EXPLEOSOL Shareholding History

JunSepDec '24MarJunSep0.06%0.21%0.49%0.33%0.10%0.13%

Mutual Funds Invested in EXPLEOSOL

Mutual Funds Invested in EXPLEOSOL

No mutual funds holding trends are available

Top 1 Mutual Funds holding Expleo Solutions Ltd

Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Motilal Oswal BSE 1000 Index Fund - Direct Plan - Growth

Growth
0.0001%0.00%-0.00%988/1023 (-19)

Compare 3-month MF holding change on Screener

EXPLEOSOL Insider Trades & Bulk Stock Deals

EXPLEOSOL Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing EXPLEOSOL stock

smallcases containing EXPLEOSOL stock

Looks like this stock is not in any smallcase yet.

EXPLEOSOL Events

EXPLEOSOL Events

EXPLEOSOL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

EXPLEOSOL Dividend Trend

No dividend trend available

EXPLEOSOL Upcoming Dividends

EXPLEOSOL Upcoming Dividends

No upcoming dividends are available

EXPLEOSOL Past Dividends

EXPLEOSOL Past Dividends

Cash Dividend

Ex DateEx DateFeb 12, 2025

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

₹50.00

Ex DateEx Date

Feb 12, 2025

Cash Dividend

Ex DateEx DateJul 14, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 14, 2023

Cash Dividend

Ex DateEx DateJul 19, 2018

Final
Final | Div/Share: ₹20.00

Dividend/Share

₹20.00

Ex DateEx Date

Jul 19, 2018

Cash Dividend

Ex DateEx DateNov 9, 2017

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

Nov 9, 2017

Cash Dividend

Ex DateEx DateJul 20, 2017

Final
Final | Div/Share: ₹20.00

Dividend/Share

₹20.00

Ex DateEx Date

Jul 20, 2017

EXPLEOSOL Stock News & Opinions

EXPLEOSOL Stock News & Opinions

Earnings
Expleo Solutions consolidated net profit rises 12.03% in the September 2025 quarter

Net profit of Expleo Solutions rose 12.03% to Rs 39.76 crore in the quarter ended September 2025 as against Rs 35.49 crore during the previous quarter ended September 2024. Sales rose 9.04% to Rs 282.70 crore in the quarter ended September 2025 as against Rs 259.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales282.70259.26 9 OPM %16.5216.31 - PBDT58.8253.99 9 PBT51.3844.47 16 NP39.7635.49 12 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Expleo Solutions to hold board meeting

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Earnings
Expleo Solutions consolidated net profit declines 14.52% in the June 2025 quarter

Net profit of Expleo Solutions declined 14.52% to Rs 20.43 crore in the quarter ended June 2025 as against Rs 23.90 crore during the previous quarter ended June 2024. Sales rose 2.97% to Rs 259.65 crore in the quarter ended June 2025 as against Rs 252.17 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales259.65252.17 3 OPM %11.4515.39 - PBDT36.0340.31 -11 PBT28.3630.95 -8 NP20.4323.90 -15 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Expleo Solutions to table results

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Expleo Solutions Ltd Slips 1.65%

Expleo Solutions Ltd fell 1.65% today to trade at Rs 1226.05. The BSE Information Technology index is down 0.24% to quote at 36751.23. The index is down 4.31 % over last one month. Among the other constituents of the index, Inventurus Knowledge Solutions Ltd decreased 0.76% and 63 Moons Technologies Ltd lost 0.69% on the day. The BSE Information Technology index went down 8.06 % over last one year compared to the 2.25% surge in benchmark SENSEX. Expleo Solutions Ltd has lost 4.2% over last one month compared to 4.31% fall in BSE Information Technology index and 0.9% rise in the SENSEX. On the BSE, 2 shares were traded in the counter so far compared with average daily volumes of 3846 shares in the past one month. The stock hit a record high of Rs 1566.95 on 20 Dec 2024. The stock hit a 52-week low of Rs 686 on 07 Apr 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Expleo Solutions schedules AGM

Expleo Solutions announced that the 27th Annual General Meeting(AGM) of the company will be held on 21 August 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Expleo Solutions standalone net profit rises 114.56% in the March 2025 quarter

Net profit of Expleo Solutions rose 114.56% to Rs 28.88 crore in the quarter ended March 2025 as against Rs 13.46 crore during the previous quarter ended March 2024. Sales rose 0.15% to Rs 255.80 crore in the quarter ended March 2025 as against Rs 255.41 crore during the previous quarter ended March 2024. For the full year,net profit rose 17.56% to Rs 95.34 crore in the year ended March 2025 as against Rs 81.10 crore during the previous year ended March 2024. Sales rose 6.21% to Rs 1024.80 crore in the year ended March 2025 as against Rs 964.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales255.80255.41 0 1024.80964.87 6 OPM %14.0412.57 -14.6314.51 - PBDT37.9432.13 18 156.93140.90 11 PBT30.0823.26 29 118.30107.87 10 NP28.8813.46 115 95.3481.10 18 Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Expleo Solutions consolidated net profit rises 53.38% in the March 2025 quarter

Net profit of Expleo Solutions rose 53.38% to Rs 24.08 crore in the quarter ended March 2025 as against Rs 15.70 crore during the previous quarter ended March 2024. Sales rose 0.15% to Rs 255.80 crore in the quarter ended March 2025 as against Rs 255.41 crore during the previous quarter ended March 2024. For the full year,net profit rose 14.15% to Rs 103.24 crore in the year ended March 2025 as against Rs 90.44 crore during the previous year ended March 2024. Sales rose 6.21% to Rs 1024.80 crore in the year ended March 2025 as against Rs 964.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales255.80255.41 0 1024.80964.87 6 OPM %15.6413.40 -16.1715.37 - PBDT43.5835.28 24 178.55153.24 17 PBT35.5226.19 36 139.24119.57 16 NP24.0815.70 53 103.2490.44 14 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Expleo Solutions schedules board meeting

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Spotlight
Expleo Solutions Ltd Slips 2.03%

Expleo Solutions Ltd fell 2.03% today to trade at Rs 840.65. The BSE Information Technology index is down 0.55% to quote at 32709.67. The index is down 7.67 % over last one month. Among the other constituents of the index, Infosys Ltd decreased 1.14% and Vakrangee Ltd lost 0.9% on the day. The BSE Information Technology index went down 4.91 % over last one year compared to the 5.08% surge in benchmark SENSEX. Expleo Solutions Ltd has lost 1.07% over last one month compared to 7.67% fall in BSE Information Technology index and 3.34% rise in the SENSEX. On the BSE, 2 shares were traded in the counter so far compared with average daily volumes of 4965 shares in the past one month. The stock hit a record high of Rs 1566.95 on 20 Dec 2024. The stock hit a 52-week low of Rs 686 on 07 Apr 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Expleo Solutions Ltd (EXPLEOSOL) today?

    The share price of EXPLEOSOL as on 5th December 2025 is ₹1052.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Expleo Solutions Ltd (EXPLEOSOL) share?

    The past returns of Expleo Solutions Ltd (EXPLEOSOL) share are
    • Past 1 week: -6.61%
    • Past 1 month: 3.84%
    • Past 3 months: 3.18%
    • Past 6 months: 0.93%
    • Past 1 year: -24.21%
    • Past 3 years: -18.27%
    • Past 5 years: 117.64%

  3. What are the peers or stocks similar to Expleo Solutions Ltd (EXPLEOSOL)?

    The peers or stocks similar to Expleo Solutions Ltd (EXPLEOSOL) include:

  4. What is the dividend yield % of Expleo Solutions Ltd (EXPLEOSOL) share?

    The current dividend yield of Expleo Solutions Ltd (EXPLEOSOL) is 4.75.

  5. What is the market cap of Expleo Solutions Ltd (EXPLEOSOL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Expleo Solutions Ltd (EXPLEOSOL) is ₹1632.99 Cr as of 5th December 2025.

  6. What is the 52 week high and low of Expleo Solutions Ltd (EXPLEOSOL) share?

    The 52-week high of Expleo Solutions Ltd (EXPLEOSOL) is ₹1567.45 and the 52-week low is ₹735.35.

  7. What is the PE and PB ratio of Expleo Solutions Ltd (EXPLEOSOL) stock?

    The P/E (price-to-earnings) ratio of Expleo Solutions Ltd (EXPLEOSOL) is 15.82. The P/B (price-to-book) ratio is 2.57.

  8. Which sector does Expleo Solutions Ltd (EXPLEOSOL) belong to?

    Expleo Solutions Ltd (EXPLEOSOL) belongs to the Information Technology sector & Software Services sub-sector.

  9. How to buy Expleo Solutions Ltd (EXPLEOSOL) shares?

    You can directly buy Expleo Solutions Ltd (EXPLEOSOL) shares on Tickertape. Simply sign up, connect your demat account and place your order.